BIOMAT Database Logo BIOMAT Database Logo

Proceedings: Oestrogen receptor activity, plasma oetrogen concentrations and response to endocrine therapy in cancer of the breast. 1976

R A Hawkins, and I McFadyen, and E Killen, and M M Roberts, and A O Langlands, and H J Stewart

UI MeSH Term Description Entries
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002369 Castration Surgical removal or artificial destruction of gonads. Gonadectomy,Castrations,Gonadectomies
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R A Hawkins, and I McFadyen, and E Killen, and M M Roberts, and A O Langlands, and H J Stewart
Oestrogen receptor in human breast cancer tissue and response to endocrine therapy.
June 1973, British medical journal,
R A Hawkins, and I McFadyen, and E Killen, and M M Roberts, and A O Langlands, and H J Stewart
Activated oestrogen receptors in breast cancer and response to endocrine therapy.
January 1984, European journal of cancer & clinical oncology,
R A Hawkins, and I McFadyen, and E Killen, and M M Roberts, and A O Langlands, and H J Stewart
Oestrogen receptors and the response to endocrine therapy in advanced breast cancer.
September 1978, British journal of cancer,
R A Hawkins, and I McFadyen, and E Killen, and M M Roberts, and A O Langlands, and H J Stewart
Oestrogen and androgen receptors in breast cancer and response to endocrine therapy.
November 1975, British medical journal,
R A Hawkins, and I McFadyen, and E Killen, and M M Roberts, and A O Langlands, and H J Stewart
Oestrogen-receptor status and endocrine therapy of breast cancer: response rates and status stability.
January 1981, British journal of cancer,
R A Hawkins, and I McFadyen, and E Killen, and M M Roberts, and A O Langlands, and H J Stewart
Quantitative oestrogen and progesterone receptor values in primary breast cancer and predictability of response to endocrine therapy.
September 1983, Clinical oncology,
R A Hawkins, and I McFadyen, and E Killen, and M M Roberts, and A O Langlands, and H J Stewart
Oestrogen and progesterone receptors and response to endocrine therapy in Japanese breast cancer.
May 1980, Journal of steroid biochemistry,
R A Hawkins, and I McFadyen, and E Killen, and M M Roberts, and A O Langlands, and H J Stewart
Prediction of response to endocrine therapy in breast cancer using immunocytochemical assays for pS2, oestrogen receptor and progesterone receptor.
June 1993, International journal of cancer,
R A Hawkins, and I McFadyen, and E Killen, and M M Roberts, and A O Langlands, and H J Stewart
Co-Expression Effect of SLC7A5/SLC3A2 to Predict Response to Endocrine Therapy in Oestrogen-Receptor-Positive Breast Cancer.
February 2020, International journal of molecular sciences,
R A Hawkins, and I McFadyen, and E Killen, and M M Roberts, and A O Langlands, and H J Stewart
CDC20 expression in oestrogen receptor positive breast cancer predicts poor prognosis and lack of response to endocrine therapy.
December 2019, Breast cancer research and treatment,
Copied contents to your clipboard!